X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene - PubMed (original) (raw)
X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene
R Jalkanen et al. J Med Genet. 2006 Aug.
Abstract
Background: X linked cone-rod dystrophy (CORDX) is a recessive retinal disease characterised by progressive dysfunction of photoreceptors. It is genetically heterogeneous, showing linkage to three X chromosomal loci. CORDX1 is caused by mutations in the RPGR gene (Xp21.1), CORDX2 is located on Xq27.2-28, and we recently localised CORDX3 to Xp11.4-q13.1. We aimed to identify the causative gene behind the CORDX3 phenotype.
Methods: All 48 exons of the CACNA1F gene were screened for mutations by DNA sequencing. RNA from cultured lymphoblasts and peripheral blood activated T lymphocytes was analysed by RT-PCR and sequencing.
Results: A novel CACNA1F mutation, IVS28-1 GCGTC>TGG, in the splice acceptor site of intron 28 was identified. Messenger RNA studies indicated that the identified mutation leads to altered splicing of the CACNA1F transcript. Aberrant splice variants are predicted to result in premature termination and deletions of the encoded protein, Ca(v)1.4 alpha1 subunit.
Conclusion: CACNA1F mutations cause the retinal disorder, incomplete congenital stationary night blindness (CSNB2), although mutations have also been detected in patients with divergent diagnoses. Our results indicate that yet another phenotype, CORDX3, is caused by a mutation in CACNA1F. Clinically, CORDX3 shares some features with CSNB2 but is distinguishable from CSNB2 in that it is progressive, can begin in adulthood, has no nystagmus or hyperopic refraction, has only low grade astigmatism, and in dark adaptation lacks cone threshold and has small or no elevation of rod threshold. Considering all features, CORDX3 is more similar to other X chromosomal cone-rod dystrophies than to CSNB2.
Conflict of interest statement
Competing interest: none declared
Figures
Similar articles
- A novel CACNA1F gene mutation causes Aland Island eye disease.
Jalkanen R, Bech-Hansen NT, Tobias R, Sankila EM, Mäntyjärvi M, Forsius H, de la Chapelle A, Alitalo T. Jalkanen R, et al. Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2498-502. doi: 10.1167/iovs.06-1103. Invest Ophthalmol Vis Sci. 2007. PMID: 17525176 - The Ca(v)1.4 calcium channel: more than meets the eye.
Doering CJ, Peloquin JB, McRory JE. Doering CJ, et al. Channels (Austin). 2007 Jan-Feb;1(1):3-10. Epub 2007 Jan 1. Channels (Austin). 2007. PMID: 19151588 Review. - A novel large in-frame deletion within the CACNA1F gene associates with a cone-rod dystrophy 3-like phenotype.
Hauke J, Schild A, Neugebauer A, Lappa A, Fricke J, Fauser S, Rösler S, Pannes A, Zarrinnam D, Altmüller J, Motameny S, Nürnberg G, Nürnberg P, Hahnen E, Beck BB. Hauke J, et al. PLoS One. 2013 Oct 4;8(10):e76414. doi: 10.1371/journal.pone.0076414. eCollection 2013. PLoS One. 2013. PMID: 24124559 Free PMC article. - Genotype and phenotype of 101 dutch patients with congenital stationary night blindness.
Bijveld MM, Florijn RJ, Bergen AA, van den Born LI, Kamermans M, Prick L, Riemslag FC, van Schooneveld MJ, Kappers AM, van Genderen MM. Bijveld MM, et al. Ophthalmology. 2013 Oct;120(10):2072-81. doi: 10.1016/j.ophtha.2013.03.002. Epub 2013 May 25. Ophthalmology. 2013. PMID: 23714322 - Mutations of RPGR in X-linked retinitis pigmentosa (RP3).
Vervoort R, Wright AF. Vervoort R, et al. Hum Mutat. 2002 May;19(5):486-500. doi: 10.1002/humu.10057. Hum Mutat. 2002. PMID: 11968081 Review.
Cited by
- Aland Island Eye Disease with Retinoschisis in the Clinical Spectrum of _CACNA1F_-Associated Retinopathy-A Case Report.
Wyględowska-Promieńska D, Świerczyńska M, Śpiewak D, Pojda-Wilczek D, Tronina A, Dorecka M, Smędowski A. Wyględowska-Promieńska D, et al. Int J Mol Sci. 2024 Mar 2;25(5):2928. doi: 10.3390/ijms25052928. Int J Mol Sci. 2024. PMID: 38474172 Free PMC article. - Four different gene-related cone-rod dystrophy: clinical and genetic findings in six Chinese families with diverse modes of inheritance.
Li Z, Cheng W, Zi F, Wang J, Huang X, Sheng X, Rong W. Li Z, et al. Front Genet. 2023 Nov 2;14:1157156. doi: 10.3389/fgene.2023.1157156. eCollection 2023. Front Genet. 2023. PMID: 38028590 Free PMC article. - Photoreceptor Ion Channels in Signaling and Disease.
Inamdar SM, Lankford CK, Baker SA. Inamdar SM, et al. Adv Exp Med Biol. 2023;1415:269-276. doi: 10.1007/978-3-031-27681-1_39. Adv Exp Med Biol. 2023. PMID: 37440044 - Mouse all-cone retina models of Cav1.4 synaptopathy.
Laird JG, Kopel A, Lankford CK, Baker SA. Laird JG, et al. Front Mol Neurosci. 2023 Apr 27;16:1155955. doi: 10.3389/fnmol.2023.1155955. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37181655 Free PMC article. - Characterization of two pathological gating-charge substitutions in Cav1.4 L-type calcium channels.
Heigl T, Netzer MA, Zanetti L, Ganglberger M, Fernández-Quintero ML, Koschak A. Heigl T, et al. Channels (Austin). 2023 Dec;17(1):2192360. doi: 10.1080/19336950.2023.2192360. Channels (Austin). 2023. PMID: 36943941 Free PMC article.
References
- Brown J, Jr, Kimura A E, Gorin M B. Clinical and electroretinographic findings of female carriers and affected males in a progressive X‐linked cone‐rod dystrophy (COD‐1) pedigree. Ophthalmology 20001071104–1110. - PubMed
- Jacobson D M, Thompson H S, Bartley J A. X‐linked progressive cone dystrophy. Clinical characteristics of affected males and female carriers. Ophthalmology 198996885–895. - PubMed
- Pinckers A, Timmerman G J M E N. Sex‐difference in progressive cone dystrophy I. Ophthalmic Paediatr Genet 1981117–23.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases